NCI National Cancer Institute www.cancer.gov U.S. National Institutes of Health

logo Bethesda

Presentations

Click on red titles to view presentations in PDF format.
Isis Mikhail

Welcome
Isis Mikhail, M.D., M.P.H., DrP.H.
Acting Chief, Clinical and Translational Epidemiology Branch, Epidemiology and Genetics Research Program
National Cancer Institute

Overview

Recommendations of the 2005 Epidemiology Workshop on Rare Cancers and Goals of This Meeting

Deborah Winn

Opening Remarks
Deborah Winn, Ph.D.
Acting Associate Director, Epidemiology and Genetics Research Program
National Cancer Institute

Rare Cancers Research in the Epidemiology and Genetics Research Program

Julie Ross

Childhood Cancer Research Network: An Effective Collaboration as a Model for Rare Cancer Research
Julie Ross, Ph.D., M.P.H
Professor and Director, Division of Pediatric Epidemiology and Clinical Research
Department of Pediatrics University of Minnesota

Bob Graham

Living with Cancer
Bob Graham
Executive Editor, Insurance and Financial Advisor Monthly

Melissa Bondy

International Study of Familial Glioma (Gliogene): Developing Successful Consortium
Melissa Bondy, Ph.D.
Professor, Department of Epidemiology
University of Texas M.D. Anderson Cancer Center

Joellen Schildkraut

The Ovarian Cancer Consortium (OCAC)
Joellen Schildkraut, Ph.D., M.P.H
Professor of Community and Family Medicine
Division of Prevention Research, Duke University Medical Center

Sara Olson

Challenges for a New Consortium (E2C2) Epidemiology of Endometrial Cancer Consortium
Sara Olson, Ph.D.
Assistant Attending Epidemiologist, Department of Epidemiology and Biostatistics
Memorial Sloan-Kettering Cancer Center

Nathaniel Rothman

Pre-Consortium Challenges: Urinary Bladder Cancer Consortium
Nathaniel Rothman, M.D., M.P.H., M.H.S,
Senior Investigator, Occupational and Environmental Epidemiology Branch
Division of Cancer Epidemiology and Genetics, National Cancer Institute

Sharon Savage

SARCOMA Working Group
Sharon Savage, M.D.
Investigator, Clinical Genetics Branch
Division of Cancer Epidemiology and Genetics, National Cancer Institute

Wong-Ho Chow

ESOPHAGEAL Cancer Working Group
Wong-Ho Chow, Ph.D.
Senior Investigator, Occupational and Environmental Epidemiology Branch
Division of Cancer Epidemiology and Genetics, National Cancer Institute

Katherine McGlynn

LIVER Cancer Working Group
Katherine McGlynn, Ph.D., M.P.H
Investigator, Hormonal and Reproductive Epidemiology Branch
Division of Cancer Epidemiology and Genetics, National Cancer Institute

Dalsu Baris

MULTIPLE MYELOMA Working Group
Dalsu Baris, M.D., Ph.D.
Staff Scientist, Occupational and Environmental Epidemiology Branch
Division of Cancer Epidemiology and Genetics, National Cancer Institute

Patricia Hartge

Cohort Consortia and Epidemiologic Research on Rare Cancers
Patricia Hartge, M.A., Sc.D.
Office of the Director
Division of Cancer Control and Population Sciences, National Cancer Institute

Marsha Reichman

Resources for Population-Based Research on Rare Cancers: NCI SEER Residual Tissue Repositories
Marsha Reichman, Ph.D.
Acting Chief, Cancer Statistics Branch Surveillance Research Coordinator
Surveillance Research Program, National Cancer Institute

Heather Spencer Feigelson

Genetic Association Studies in Clinically Important Subtypes of Breast and Prostate Cancer: Lessons from the Breast and Prostate Cancer Consortium (BPC3)
Heather Spencer Feigelson, Ph.D., M.P.H,
Strategic Director of Genetic Epidemiology
Department of Epidemiology and Surveillance Research, American Cancer Society

Graham Colditz

METHODS & STRATEGIES Working Group I
Graham Colditz, M.D., Dr. P.H.
Niess-Gain Professor, Department of Surgery, and
Associate Director, Prevention and Control, Alvin J. Siteman Cancer Center
Washington University School of Medicine

Wendy Cozen

METHODS & STRATEGIES Working Group II
Wendy Cozen, D.O., M.P.H.
Associate Professor, Department of Preventive Medicine
Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California

David Hunter

METHODS & STRATEGIES Working Group III
David Hunter, M.B.B.S., M.P.H., Sc.D.
Vincent L. Gregory Professor in Cancer Prevention
Department of Epidemiology and Nutrition, Harvard School of Public Health

Sara Strom

METHODS & STRATEGIES Working Group IV
Sara Strom, Ph.D.
Assistant Professor, Department of Epidemiology
University of Texas, MD Anderson Cancer Center

Robert Hoover

Genome Wide Association and Rare Cancers
Robert Hoover, M.D., Sc.D.
Director, Epidemiology and Biostatistics Program
Division of Cancer Epidemiology and Genetics, National Cancer Institute

Peter Schad

Utilizing Informatics to Foster Collaboration and Networking: Challenges and Opportunities
Peter Schad, Ph.D.
Health Informatics Coordinator
Division of Cancer Control and Population Sciences, National Cancer Institute

Manal Hassan

Epidemiology of Hepatocellular Carcinoma in USA
Manal Hassan, M.D., Ph.D.
Assistant Professor, Department of Gastrointestinal Medical Oncology
University of Texas, MD Anderson Cancer Center

Brenda Edwards

Rare Cancers in the United States and Worldwide
Brenda Edwards, Ph.D.
Associate Director, Surveillance Research Program
National Cancer Institute

Rashmi Gopal-Srivastava

Rare Diseases Clinical Research Network (RDCRN): A Network of Consortia and the Role of Data Technology Coordinating Center (DTCC)
Rashmi Gopal-Srivastava, Ph.D.
Director, Extramural Research Program
Office of Rare Diseases, National Institute of Health

Richard Gorlick

Consumer Advocates in Research and Related Activities (CARRA) Program
Richard Gorlick, M.D.
Associate Professor of Pediatrics and Molecular Pharmacology
Albert Einstein College of Medicine, and
Vice Chairman, Division Chief, Department of Pediatrics Hematology/Oncology
the Children's Hospital at Montefiore

Nancy O'Hagan

Dedicated to Discovering a Cure for Carcinoid
Nancy O'Hagan, J.D.
President and Founder Caring for Carcinoid Foundation

Sholom Wacholder

Studies of Rare Cancers
Sholom Wacholder, Ph.D.
Senior Investigator
Division of Cancer Epidemiology and Genetics, National Cancer Institute

Last Updated: 23 Oct 2009

Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov